Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer

− If Approved in the European Union, Fruquintinib Will Be the First Novel Targeted Therapy for Metastatic Colorectal Cancer Regardless of Biomarker Status in Over a Decade Read More

Ads Links by Easy Branches
Play online games for free at games.easybranches.com

Guest Post Services www.easybranches.com/contribute
Auto theft crisis deepens as insurance claims top $1.5 billion for first time
Five things to watch for in the Canadian business world in the coming week

Southern Russian Oil Refinery Struck, Kharkiv Takes Another Hit
Economists to have a close eye on April inflation report as BoC rate decision nears